330 related articles for article (PubMed ID: 20305616)
1. Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients.
Scarpa A; Mantovani W; Capelli P; Beghelli S; Boninsegna L; Bettini R; Panzuto F; Pederzoli P; delle Fave G; Falconi M
Mod Pathol; 2010 Jun; 23(6):824-33. PubMed ID: 20305616
[TBL] [Abstract][Full Text] [Related]
2. TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study.
Rindi G; Falconi M; Klersy C; Albarello L; Boninsegna L; Buchler MW; Capella C; Caplin M; Couvelard A; Doglioni C; Delle Fave G; Fischer L; Fusai G; de Herder WW; Jann H; Komminoth P; de Krijger RR; La Rosa S; Luong TV; Pape U; Perren A; Ruszniewski P; Scarpa A; Schmitt A; Solcia E; Wiedenmann B
J Natl Cancer Inst; 2012 May; 104(10):764-77. PubMed ID: 22525418
[TBL] [Abstract][Full Text] [Related]
3. Comparison of WHO Classifications (2004, 2010), the Hochwald grading system, and AJCC and ENETS staging systems in predicting prognosis in locoregional well-differentiated pancreatic neuroendocrine tumors.
Liu TC; Hamilton N; Hawkins W; Gao F; Cao D
Am J Surg Pathol; 2013 Jun; 37(6):853-9. PubMed ID: 23598967
[TBL] [Abstract][Full Text] [Related]
4. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE).
Nuñez-Valdovinos B; Carmona-Bayonas A; Jimenez-Fonseca P; Capdevila J; Castaño-Pascual Á; Benavent M; Pi Barrio JJ; Teule A; Alonso V; Custodio A; Marazuela M; Segura Á; Beguiristain A; Llanos M; Martinez Del Prado MP; Diaz-Perez JA; Castellano D; Sevilla I; Lopez C; Alonso T; Garcia-Carbonero R
Oncologist; 2018 Apr; 23(4):422-432. PubMed ID: 29330208
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors and survival after surgical resection of pancreatic neuroendocrine tumor with validation of established and modified staging systems.
Benetatos N; Hodson J; Marudanayagam R; Sutcliffe RP; Isaac JR; Ayuk J; Shah T; Roberts KJ
Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):169-175. PubMed ID: 29576279
[TBL] [Abstract][Full Text] [Related]
6. TNM staging of pancreatic neuroendocrine tumors: an observational analysis and comparison by both AJCC and ENETS systems from 1 single institution.
Yang M; Zeng L; Zhang Y; Wang WG; Wang L; Ke NW; Liu XB; Tian BL
Medicine (Baltimore); 2015 Mar; 94(12):e660. PubMed ID: 25816036
[TBL] [Abstract][Full Text] [Related]
7. pT but not pN stage of the 8th TNM classification significantly improves prognostication in pancreatic ductal adenocarcinoma.
Schlitter AM; Jesinghaus M; Jäger C; Konukiewitz B; Muckenhuber A; Demir IE; Bahra M; Denkert C; Friess H; Kloeppel G; Ceyhan GO; Weichert W
Eur J Cancer; 2017 Oct; 84():121-129. PubMed ID: 28802189
[TBL] [Abstract][Full Text] [Related]
8. Modified Staging Classification for Pancreatic Neuroendocrine Tumors on the Basis of the American Joint Committee on Cancer and European Neuroendocrine Tumor Society Systems.
Luo G; Javed A; Strosberg JR; Jin K; Zhang Y; Liu C; Xu J; Soares K; Weiss MJ; Zheng L; Wolfgang CL; Cives M; Wong J; Wang W; Sun J; Shao C; Wang W; Tan H; Li J; Ni Q; Shen L; Chen M; He J; Chen J; Yu X
J Clin Oncol; 2017 Jan; 35(3):274-280. PubMed ID: 27646952
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors at diagnosis and value of WHO classification in a mono-institutional series of 180 non-functioning pancreatic endocrine tumours.
Bettini R; Boninsegna L; Mantovani W; Capelli P; Bassi C; Pederzoli P; Delle Fave GF; Panzuto F; Scarpa A; Falconi M
Ann Oncol; 2008 May; 19(5):903-8. PubMed ID: 18209014
[TBL] [Abstract][Full Text] [Related]
10. Grading of well-differentiated pancreatic neuroendocrine tumors is improved by the inclusion of both Ki67 proliferative index and mitotic rate.
McCall CM; Shi C; Cornish TC; Klimstra DS; Tang LH; Basturk O; Mun LJ; Ellison TA; Wolfgang CL; Choti MA; Schulick RD; Edil BH; Hruban RH
Am J Surg Pathol; 2013 Nov; 37(11):1671-7. PubMed ID: 24121170
[TBL] [Abstract][Full Text] [Related]
11. Surgery and staging of pancreatic neuroendocrine tumors: a 14-year experience.
Ito H; Abramson M; Ito K; Swanson E; Cho N; Ruan DT; Swanson RS; Whang EE
J Gastrointest Surg; 2010 May; 14(5):891-8. PubMed ID: 20224984
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic study of 62 acinar cell carcinomas of the pancreas: insights into the morphology and immunophenotype and search for prognostic markers.
La Rosa S; Adsay V; Albarello L; Asioli S; Casnedi S; Franzi F; Marando A; Notohara K; Sessa F; Vanoli A; Zhang L; Capella C
Am J Surg Pathol; 2012 Dec; 36(12):1782-95. PubMed ID: 23026929
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the World Health Organization 2010 grading system in surgical outcome and prognosis of pancreatic neuroendocrine tumors.
Yang M; Tian BL; Zhang Y; Su AP; Yue PJ; Xu S; Wang L
Pancreas; 2014 Oct; 43(7):1003-8. PubMed ID: 24945681
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of grade of malignancy based on histopathological differentiation and Ki-67 in pancreatic ductal adenocarcinoma.
Liang Y; Sheng G; Guo Y; Zou Y; Guo H; Li Z; Chang S; Man Q; Gao S; Hao J
Cancer Biol Med; 2024 Jan; 21(5):416-32. PubMed ID: 38172499
[TBL] [Abstract][Full Text] [Related]
15. Ki-67 Index of 5% is Better Than 2% in Stratifying G1 and G2 of the World Health Organization Grading System in Pancreatic Neuroendocrine Tumors.
Gao SW; Huang CS; Huang XT; Chen LH; Chen W; Cai JP; Yin XY
Pancreas; 2019 Jul; 48(6):795-798. PubMed ID: 31210659
[TBL] [Abstract][Full Text] [Related]
16. Validation of the 2010 WHO classification and a new prognostic proposal: A single centre retrospective study of well-differentiated pancreatic neuroendocrine tumours.
Ricci C; Casadei R; Taffurelli G; Campana D; Ambrosini V; Pagano N; Santini D; De Giorgio R; Ingaldi C; Tomassetti P; Zani E; Minni F
Pancreatology; 2016; 16(3):403-10. PubMed ID: 26924664
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Validity of the American Joint Committee on Cancer and the European Neuroendocrine Tumors Staging Classifications for Pancreatic Neuroendocrine Tumors: A Retrospective Nationwide Multicenter Study in South Korea.
Cho JH; Ryu JK; Song SY; Hwang JH; Lee DK; Woo SM; Joo YE; Jeong S; Lee SO; Park BK; Cheon YK; Han J; Kim TN; Lee JK; Moon SH; Kim H; Park ET; Hwang JC; Kim TH; Jeon TJ; Cho CM; Choi HS; Lee WJ
Pancreas; 2016 Aug; 45(7):941-6. PubMed ID: 26765964
[TBL] [Abstract][Full Text] [Related]
18. Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors.
Pape UF; Jann H; Müller-Nordhorn J; Bockelbrink A; Berndt U; Willich SN; Koch M; Röcken C; Rindi G; Wiedenmann B
Cancer; 2008 Jul; 113(2):256-65. PubMed ID: 18506737
[TBL] [Abstract][Full Text] [Related]
19. Comparison of World Health Organization 2000/2004 and World Health Organization 2010 classifications for gastrointestinal and pancreatic neuroendocrine tumors.
Pasaoglu E; Dursun N; Ozyalvacli G; Hacihasanoglu E; Behzatoglu K; Calay O
Ann Diagn Pathol; 2015 Apr; 19(2):81-7. PubMed ID: 25702616
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors and survival in 324 patients with pancreatic endocrine tumor treated at a single institution.
Ekeblad S; Skogseid B; Dunder K; Oberg K; Eriksson B
Clin Cancer Res; 2008 Dec; 14(23):7798-803. PubMed ID: 19047107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
